

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.83046654 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.70016471 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.70016471 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 5.68065158 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.44690034 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.44690034 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.44690034 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.44690034 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.44690034 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.44690034 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.27381787 |
| 12 | leukocyte aggregation (GO:0070486) | 5.06905718 |
| 13 | detection of other organism (GO:0098543) | 4.98321816 |
| 14 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.96430886 |
| 15 | response to peptidoglycan (GO:0032494) | 4.91243303 |
| 16 | detection of bacterium (GO:0016045) | 4.81315237 |
| 17 | cellular extravasation (GO:0045123) | 4.76122989 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.74646618 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.65819182 |
| 20 | neutrophil activation (GO:0042119) | 4.65496948 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.44059139 |
| 22 | activated T cell proliferation (GO:0050798) | 4.43414010 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.39420955 |
| 24 | microglial cell activation (GO:0001774) | 4.29280348 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.28432280 |
| 26 | respiratory burst (GO:0045730) | 4.20794381 |
| 27 | detection of external biotic stimulus (GO:0098581) | 4.10020948 |
| 28 | defense response to fungus (GO:0050832) | 4.07124462 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.06187385 |
| 30 | regulation of mast cell degranulation (GO:0043304) | 4.06121127 |
| 31 | granulocyte activation (GO:0036230) | 4.05209262 |
| 32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.02842618 |
| 33 | myeloid cell activation involved in immune response (GO:0002275) | 3.99327542 |
| 34 | positive regulation of mast cell activation (GO:0033005) | 3.98665081 |
| 35 | negative regulation of interleukin-12 production (GO:0032695) | 3.96649415 |
| 36 | response to host immune response (GO:0052572) | 3.96520264 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.96520264 |
| 38 | neutrophil mediated immunity (GO:0002446) | 3.93518460 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 3.90867313 |
| 40 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.90522134 |
| 41 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.89381461 |
| 42 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.89223979 |
| 43 | regulation of mast cell activation (GO:0033003) | 3.86387684 |
| 44 | negative regulation of phagocytosis (GO:0050765) | 3.79402446 |
| 45 | leukocyte degranulation (GO:0043299) | 3.78838992 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.76425134 |
| 47 | detection of molecule of bacterial origin (GO:0032490) | 3.72226715 |
| 48 | detection of biotic stimulus (GO:0009595) | 3.71292776 |
| 49 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.68542462 |
| 50 | response to interleukin-15 (GO:0070672) | 3.67838957 |
| 51 | mast cell activation (GO:0045576) | 3.66736027 |
| 52 | cellular response to interleukin-15 (GO:0071350) | 3.66476465 |
| 53 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.64548302 |
| 54 | response to fungus (GO:0009620) | 3.56861294 |
| 55 | macrophage activation (GO:0042116) | 3.56001174 |
| 56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.53315369 |
| 57 | response to host (GO:0075136) | 3.53315369 |
| 58 | response to host defenses (GO:0052200) | 3.53315369 |
| 59 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.52336741 |
| 60 | positive regulation of mast cell degranulation (GO:0043306) | 3.52336741 |
| 61 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.48940714 |
| 62 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.44421370 |
| 63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.42105789 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 3.41893594 |
| 65 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.37973793 |
| 66 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.37973793 |
| 67 | negative regulation of interleukin-6 production (GO:0032715) | 3.35338103 |
| 68 | myeloid leukocyte mediated immunity (GO:0002444) | 3.32195682 |
| 69 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.29966927 |
| 70 | regulation of leukocyte degranulation (GO:0043300) | 3.28631234 |
| 71 | cell wall macromolecule catabolic process (GO:0016998) | 3.23741988 |
| 72 | positive regulation of B cell differentiation (GO:0045579) | 3.23012775 |
| 73 | regulation of B cell differentiation (GO:0045577) | 3.17828499 |
| 74 | negative regulation of interleukin-1 production (GO:0032692) | 3.15953697 |
| 75 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.14341510 |
| 76 | defense response to protozoan (GO:0042832) | 3.14190572 |
| 77 | tolerance induction (GO:0002507) | 3.11740392 |
| 78 | B cell receptor signaling pathway (GO:0050853) | 3.10514210 |
| 79 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.09847144 |
| 80 | mast cell activation involved in immune response (GO:0002279) | 3.06757494 |
| 81 | mast cell degranulation (GO:0043303) | 3.06757494 |
| 82 | killing of cells of other organism (GO:0031640) | 3.05063711 |
| 83 | disruption of cells of other organism (GO:0044364) | 3.05063711 |
| 84 | regulation of tolerance induction (GO:0002643) | 3.02793186 |
| 85 | B cell mediated immunity (GO:0019724) | 3.01583206 |
| 86 | response to muramyl dipeptide (GO:0032495) | 2.99045403 |
| 87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.98589635 |
| 88 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.98295938 |
| 89 | superoxide anion generation (GO:0042554) | 2.97310426 |
| 90 | regulation of regulated secretory pathway (GO:1903305) | 2.96396878 |
| 91 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.94570095 |
| 92 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.92663609 |
| 93 | positive regulation of granulocyte differentiation (GO:0030854) | 2.90845595 |
| 94 | myeloid leukocyte activation (GO:0002274) | 2.90601244 |
| 95 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.90157335 |
| 96 | interferon-gamma production (GO:0032609) | 2.89885278 |
| 97 | regulation of T cell tolerance induction (GO:0002664) | 2.89867870 |
| 98 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.89588990 |
| 99 | neutrophil chemotaxis (GO:0030593) | 2.89069937 |
| 100 | response to protozoan (GO:0001562) | 2.83148991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.54249578 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.98637565 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.98706241 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.73817951 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.67212953 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.16742121 |
| 7 | SPI1_23547873_ChIP-Seq_NB4_Human | 3.08157509 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.03919165 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.99397449 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.96694996 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.90129259 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.84141841 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.76756727 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.61169040 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59022177 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.54847046 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.48486293 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.48259556 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.47575941 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.42350921 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41723618 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.41092163 |
| 23 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39433537 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26672688 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16106231 |
| 26 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15880983 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.05238694 |
| 28 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.04193973 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.03020223 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 2.02254824 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 2.00240802 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.96074922 |
| 33 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.93674409 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.91851886 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87045761 |
| 36 | GATA3_26560356_Chip-Seq_TH2_Human | 1.84138727 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79834199 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68325815 |
| 39 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.64999083 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.62191199 |
| 41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.60007248 |
| 42 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58019615 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54782115 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52482188 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51552612 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50169055 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49981740 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.48024513 |
| 49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44252862 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43691010 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40715964 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38827834 |
| 53 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35713896 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32030081 |
| 55 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29389479 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28762220 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26612040 |
| 58 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20495393 |
| 59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20403681 |
| 60 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20234989 |
| 61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19347064 |
| 62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19344649 |
| 63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18873003 |
| 64 | MYC_22102868_ChIP-Seq_BL_Human | 1.15219943 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13323233 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10863814 |
| 67 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.10619917 |
| 68 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09899227 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09761893 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08972591 |
| 71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08899567 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08083326 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06886065 |
| 74 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.06313803 |
| 75 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05361026 |
| 76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05201846 |
| 77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.05081875 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04425614 |
| 79 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01753661 |
| 80 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.99651124 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99496318 |
| 82 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98776256 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98522146 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96451459 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96331742 |
| 86 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95924162 |
| 87 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95885916 |
| 88 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95488610 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95089858 |
| 90 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94350609 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.92774023 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91803453 |
| 93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91422216 |
| 94 | P300_27268052_Chip-Seq_Bcells_Human | 0.90552025 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87459454 |
| 96 | GATA3_26560356_Chip-Seq_TH1_Human | 0.86713724 |
| 97 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.86295383 |
| 98 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86052505 |
| 99 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85574170 |
| 100 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.84838383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.67699812 |
| 2 | MP0003436_decreased_susceptibility_to | 4.05819208 |
| 3 | MP0006082_CNS_inflammation | 3.82153085 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.57710247 |
| 5 | MP0002419_abnormal_innate_immunity | 3.25111700 |
| 6 | MP0005671_abnormal_response_to | 3.12868888 |
| 7 | MP0009785_altered_susceptibility_to | 3.10342806 |
| 8 | MP0001800_abnormal_humoral_immune | 2.96545999 |
| 9 | MP0005025_abnormal_response_to | 2.92338817 |
| 10 | MP0002132_abnormal_respiratory_system | 2.87742515 |
| 11 | MP0003303_peritoneal_inflammation | 2.87116459 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.74221493 |
| 13 | MP0002723_abnormal_immune_serum | 2.61289390 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.56155676 |
| 15 | MP0001819_abnormal_immune_cell | 2.53591408 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.52180406 |
| 17 | MP0005387_immune_system_phenotype | 2.49234842 |
| 18 | MP0001790_abnormal_immune_system | 2.49234842 |
| 19 | MP0000685_abnormal_immune_system | 2.41372906 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.29636770 |
| 21 | MP0002405_respiratory_system_inflammati | 2.21464800 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.06764676 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.06505890 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.99983127 |
| 25 | MP0002398_abnormal_bone_marrow | 1.96830759 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.95936730 |
| 27 | MP0000716_abnormal_immune_system | 1.91720427 |
| 28 | MP0003828_pulmonary_edema | 1.89137582 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.82979559 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.78284392 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.78284392 |
| 32 | MP0009764_decreased_sensitivity_to | 1.73762061 |
| 33 | MP0009278_abnormal_bone_marrow | 1.71858307 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.67956058 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.65124735 |
| 36 | MP0002722_abnormal_immune_system | 1.64986641 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.64103847 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.62097840 |
| 39 | MP0004510_myositis | 1.60797909 |
| 40 | MP0001873_stomach_inflammation | 1.59947014 |
| 41 | MP0008469_abnormal_protein_level | 1.55931777 |
| 42 | MP0002429_abnormal_blood_cell | 1.52009381 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.51477073 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.47893612 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.40265399 |
| 46 | MP0003866_abnormal_defecation | 1.37784720 |
| 47 | MP0001986_abnormal_taste_sensitivity | 1.35402762 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.32724018 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.32576565 |
| 50 | MP0008260_abnormal_autophagy | 1.31246525 |
| 51 | MP0001851_eye_inflammation | 1.30383848 |
| 52 | MP0004883_abnormal_blood_vessel | 1.29652727 |
| 53 | MP0004947_skin_inflammation | 1.29343466 |
| 54 | MP0005083_abnormal_biliary_tract | 1.28460634 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.26828276 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.21076273 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.18631063 |
| 58 | MP0005310_abnormal_salivary_gland | 1.10436071 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 1.10161487 |
| 60 | MP0001663_abnormal_digestive_system | 1.07599148 |
| 61 | MP0000858_altered_metastatic_potential | 1.06059701 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.05807842 |
| 63 | MP0005164_abnormal_response_to | 0.98636583 |
| 64 | MP0002166_altered_tumor_susceptibility | 0.98389128 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 0.97854343 |
| 66 | MP0002933_joint_inflammation | 0.96539103 |
| 67 | MP0002928_abnormal_bile_duct | 0.95691696 |
| 68 | MP0009765_abnormal_xenobiotic_induced | 0.93469537 |
| 69 | MP0004381_abnormal_hair_follicle | 0.91245973 |
| 70 | MP0002998_abnormal_bone_remodeling | 0.90189453 |
| 71 | MP0009763_increased_sensitivity_to | 0.86798593 |
| 72 | MP0005174_abnormal_tail_pigmentation | 0.85368828 |
| 73 | MP0003075_altered_response_to | 0.85149436 |
| 74 | MP0001853_heart_inflammation | 0.82104244 |
| 75 | MP0005451_abnormal_body_composition | 0.81155637 |
| 76 | MP0005390_skeleton_phenotype | 0.78917568 |
| 77 | MP0003252_abnormal_bile_duct | 0.77327246 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 0.76993896 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 0.74723645 |
| 80 | MP0002653_abnormal_ependyma_morphology | 0.70594756 |
| 81 | MP0008004_abnormal_stomach_pH | 0.69892729 |
| 82 | MP0005166_decreased_susceptibility_to | 0.69595700 |
| 83 | MP0000343_altered_response_to | 0.69556349 |
| 84 | MP0003690_abnormal_glial_cell | 0.69477786 |
| 85 | MP0004808_abnormal_hematopoietic_stem | 0.64503532 |
| 86 | MP0002006_tumorigenesis | 0.60850578 |
| 87 | MP0003878_abnormal_ear_physiology | 0.60025789 |
| 88 | MP0005377_hearing/vestibular/ear_phenot | 0.60025789 |
| 89 | MP0000490_abnormal_crypts_of | 0.58137654 |
| 90 | MP0004130_abnormal_muscle_cell | 0.57725419 |
| 91 | MP0000569_abnormal_digit_pigmentation | 0.56707684 |
| 92 | MP0003795_abnormal_bone_structure | 0.55583768 |
| 93 | MP0003787_abnormal_imprinting | 0.54494712 |
| 94 | MP0003195_calcinosis | 0.54241287 |
| 95 | MP0000249_abnormal_blood_vessel | 0.53209187 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.51970707 |
| 97 | MP0004484_altered_response_of | 0.51095823 |
| 98 | MP0003879_abnormal_hair_cell | 0.49818859 |
| 99 | MP0002133_abnormal_respiratory_system | 0.49429911 |
| 100 | MP0005388_respiratory_system_phenotype | 0.49429911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 5.92515268 |
| 2 | Stomatitis (HP:0010280) | 5.92352480 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.65562427 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.56585137 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.51585149 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.51116292 |
| 7 | Abnormality of macrophages (HP:0004311) | 5.06665683 |
| 8 | Orchitis (HP:0100796) | 4.90500134 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.80477054 |
| 10 | Optic neuritis (HP:0100653) | 4.80477054 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.65139963 |
| 12 | Hypochromic microcytic anemia (HP:0004840) | 4.44362385 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.36704544 |
| 14 | Obstructive lung disease (HP:0006536) | 4.24722907 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.24722907 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.99876739 |
| 17 | Prolonged bleeding time (HP:0003010) | 3.88429076 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.84195185 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.84195185 |
| 20 | Recurrent skin infections (HP:0001581) | 3.84152391 |
| 21 | Meningitis (HP:0001287) | 3.64486850 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.63377755 |
| 23 | Encephalitis (HP:0002383) | 3.58340103 |
| 24 | Hypochromic anemia (HP:0001931) | 3.53989791 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.53492608 |
| 26 | Urticaria (HP:0001025) | 3.38058197 |
| 27 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.36469274 |
| 28 | Keratoconjunctivitis sicca (HP:0001097) | 3.35075805 |
| 29 | Vasculitis (HP:0002633) | 3.25838484 |
| 30 | Keratoconjunctivitis (HP:0001096) | 3.25780919 |
| 31 | Petechiae (HP:0000967) | 3.25325657 |
| 32 | Episodic fever (HP:0001954) | 3.08525419 |
| 33 | Leukocytosis (HP:0001974) | 3.04880086 |
| 34 | Abnormality of T cells (HP:0002843) | 3.03578878 |
| 35 | Chest pain (HP:0100749) | 3.01739028 |
| 36 | Hemoptysis (HP:0002105) | 3.01482737 |
| 37 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.00523350 |
| 38 | Constricted visual fields (HP:0001133) | 2.99951713 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 2.99270759 |
| 40 | Gingivitis (HP:0000230) | 2.89463506 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.86022839 |
| 42 | Gingival bleeding (HP:0000225) | 2.84377811 |
| 43 | Epistaxis (HP:0000421) | 2.79332225 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.74351364 |
| 45 | T lymphocytopenia (HP:0005403) | 2.68845091 |
| 46 | Granulocytopenia (HP:0001913) | 2.66264068 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.66199101 |
| 48 | Pustule (HP:0200039) | 2.65425818 |
| 49 | Increased IgE level (HP:0003212) | 2.64885587 |
| 50 | Increased IgM level (HP:0003496) | 2.64674166 |
| 51 | Arterial thrombosis (HP:0004420) | 2.61683003 |
| 52 | Microcytic anemia (HP:0001935) | 2.59921852 |
| 53 | Panhypogammaglobulinemia (HP:0003139) | 2.59862676 |
| 54 | Toxemia of pregnancy (HP:0100603) | 2.57270622 |
| 55 | Anorexia (HP:0002039) | 2.57268443 |
| 56 | Inflammation of the large intestine (HP:0002037) | 2.44744032 |
| 57 | Eosinophilia (HP:0001880) | 2.43025604 |
| 58 | Recurrent viral infections (HP:0004429) | 2.41983527 |
| 59 | Metaphyseal cupping (HP:0003021) | 2.40314827 |
| 60 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.39156275 |
| 61 | Amyloidosis (HP:0011034) | 2.37429192 |
| 62 | Pulmonary embolism (HP:0002204) | 2.34062586 |
| 63 | Abnormality of eosinophils (HP:0001879) | 2.33225632 |
| 64 | Gangrene (HP:0100758) | 2.31907071 |
| 65 | Gastrointestinal inflammation (HP:0004386) | 2.29995788 |
| 66 | Cellulitis (HP:0100658) | 2.29443418 |
| 67 | Abnormality of the pleura (HP:0002103) | 2.27427056 |
| 68 | Thrombocytosis (HP:0001894) | 2.24479352 |
| 69 | Abnormality of macular pigmentation (HP:0008002) | 2.24332794 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.20317403 |
| 71 | Hypergammaglobulinemia (HP:0010702) | 2.17453370 |
| 72 | Stomach cancer (HP:0012126) | 2.16788297 |
| 73 | Osteomyelitis (HP:0002754) | 2.13278417 |
| 74 | Keratitis (HP:0000491) | 2.07388182 |
| 75 | IgM deficiency (HP:0002850) | 2.06978690 |
| 76 | Hepatosplenomegaly (HP:0001433) | 2.06157989 |
| 77 | Lymphopenia (HP:0001888) | 2.06068198 |
| 78 | Increased serum ferritin (HP:0003281) | 2.05772645 |
| 79 | Sepsis (HP:0100806) | 2.04397821 |
| 80 | Vertigo (HP:0002321) | 2.04266643 |
| 81 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03544177 |
| 82 | Nasal polyposis (HP:0100582) | 2.03180797 |
| 83 | Attenuation of retinal blood vessels (HP:0007843) | 2.02998602 |
| 84 | Cheilitis (HP:0100825) | 1.95939302 |
| 85 | Autoimmune hemolytic anemia (HP:0001890) | 1.95193237 |
| 86 | Increased cerebral lipofuscin (HP:0011813) | 1.93484637 |
| 87 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89607318 |
| 88 | Abnormality of B cell number (HP:0010975) | 1.89385304 |
| 89 | Skin rash (HP:0000988) | 1.88094263 |
| 90 | Autoimmune thrombocytopenia (HP:0001973) | 1.87938877 |
| 91 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.87390022 |
| 92 | Hemiplegia (HP:0002301) | 1.85919011 |
| 93 | IgG deficiency (HP:0004315) | 1.84795407 |
| 94 | Severe visual impairment (HP:0001141) | 1.82418861 |
| 95 | Hematochezia (HP:0002573) | 1.82239463 |
| 96 | Poikilocytosis (HP:0004447) | 1.82041812 |
| 97 | Glomerulopathy (HP:0100820) | 1.81965023 |
| 98 | Recurrent sinusitis (HP:0011108) | 1.81369138 |
| 99 | Abnormality of the pericardium (HP:0001697) | 1.80713231 |
| 100 | Abnormal platelet volume (HP:0011876) | 1.79494172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.16603255 |
| 2 | FES | 3.83521574 |
| 3 | MAP4K1 | 3.38125755 |
| 4 | BLK | 3.14995302 |
| 5 | MAP2K3 | 2.97185001 |
| 6 | KIT | 2.88148948 |
| 7 | IRAK4 | 2.79685661 |
| 8 | GRK6 | 2.73323027 |
| 9 | CSK | 2.56442674 |
| 10 | TXK | 2.54395190 |
| 11 | TNK2 | 2.41124926 |
| 12 | ZAP70 | 2.34680590 |
| 13 | CDK19 | 2.18915349 |
| 14 | SYK | 2.16061409 |
| 15 | ERN1 | 2.07854140 |
| 16 | BTK | 2.07034907 |
| 17 | TEC | 2.04440781 |
| 18 | TYK2 | 2.03761304 |
| 19 | JAK3 | 1.83502705 |
| 20 | ITK | 1.71095304 |
| 21 | MAP3K3 | 1.66501541 |
| 22 | HCK | 1.64979548 |
| 23 | TAOK1 | 1.62514361 |
| 24 | FGR | 1.61288579 |
| 25 | LYN | 1.60773340 |
| 26 | TBK1 | 1.59446940 |
| 27 | IKBKE | 1.58330395 |
| 28 | TAOK3 | 1.48036206 |
| 29 | PTK2B | 1.42060607 |
| 30 | IKBKB | 1.40457639 |
| 31 | MAP3K14 | 1.40337627 |
| 32 | MAP3K11 | 1.36392126 |
| 33 | EPHB1 | 1.28785358 |
| 34 | MATK | 1.23589986 |
| 35 | CSF1R | 1.22814262 |
| 36 | JAK2 | 1.22551360 |
| 37 | LCK | 1.21742913 |
| 38 | FRK | 1.16951878 |
| 39 | IRAK1 | 1.14242822 |
| 40 | SIK3 | 1.13323982 |
| 41 | MARK3 | 1.10480449 |
| 42 | MAP4K2 | 1.10405657 |
| 43 | PRPF4B | 0.98761563 |
| 44 | SIK2 | 0.97196875 |
| 45 | JAK1 | 0.87218077 |
| 46 | OXSR1 | 0.86691273 |
| 47 | MAP3K7 | 0.83197543 |
| 48 | PDK1 | 0.81931263 |
| 49 | STK38 | 0.80205524 |
| 50 | PIK3CG | 0.79453495 |
| 51 | PRKCQ | 0.79184428 |
| 52 | MAP3K1 | 0.79025126 |
| 53 | YES1 | 0.77614276 |
| 54 | PRKD2 | 0.73401448 |
| 55 | DAPK2 | 0.70926250 |
| 56 | PIM1 | 0.70924682 |
| 57 | NUAK1 | 0.70917180 |
| 58 | MARK2 | 0.66709196 |
| 59 | MAPK7 | 0.64552536 |
| 60 | TAOK2 | 0.64423121 |
| 61 | BMPR2 | 0.63641736 |
| 62 | FYN | 0.63491963 |
| 63 | TESK2 | 0.61484522 |
| 64 | ADRBK2 | 0.61466711 |
| 65 | STK11 | 0.61393551 |
| 66 | TRIM28 | 0.58996737 |
| 67 | PDPK1 | 0.58155474 |
| 68 | MAP2K4 | 0.57541121 |
| 69 | STK10 | 0.56976352 |
| 70 | INSRR | 0.53033299 |
| 71 | IRAK2 | 0.52896814 |
| 72 | MAP3K13 | 0.49947856 |
| 73 | MAP3K5 | 0.47640901 |
| 74 | PRKG2 | 0.44307119 |
| 75 | ABL1 | 0.42447948 |
| 76 | MAP2K6 | 0.41984385 |
| 77 | LRRK2 | 0.40601925 |
| 78 | PRKCZ | 0.38717660 |
| 79 | PRKCD | 0.37828990 |
| 80 | GRK7 | 0.37742490 |
| 81 | TGFBR2 | 0.36721463 |
| 82 | EPHA3 | 0.36496658 |
| 83 | PTK6 | 0.36064442 |
| 84 | MAP3K6 | 0.36022868 |
| 85 | BCKDK | 0.34347897 |
| 86 | ADRBK1 | 0.34265629 |
| 87 | RPS6KA6 | 0.33187474 |
| 88 | MAP2K2 | 0.32935786 |
| 89 | RAF1 | 0.31585627 |
| 90 | HIPK2 | 0.30169037 |
| 91 | KSR2 | 0.29969110 |
| 92 | MAPK12 | 0.29907794 |
| 93 | RPS6KA4 | 0.28015542 |
| 94 | RPS6KL1 | 0.27892005 |
| 95 | RPS6KC1 | 0.27892005 |
| 96 | WNK3 | 0.27286795 |
| 97 | RET | 0.27113644 |
| 98 | INSR | 0.23637763 |
| 99 | KSR1 | 0.22916126 |
| 100 | PRKAA2 | 0.22589632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.18000566 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.04462388 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.00220817 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.84108510 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.81580807 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.60492712 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.46559195 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.31289261 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.29722280 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.19338609 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.16052915 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.14865365 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.12466684 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.07462467 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.96530702 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88052713 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.87379994 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.78617277 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76822909 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.75913810 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.74489914 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.71868377 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.69358294 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.67179802 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.66553691 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.61439649 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.57432161 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.52333410 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.43123355 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.40723279 |
| 31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.36196969 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.32194111 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.26208946 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25922622 |
| 35 | Platelet activation_Homo sapiens_hsa04611 | 1.22131848 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21215259 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20938890 |
| 38 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.18176106 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.17180969 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16483043 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.16321950 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14265267 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.12608940 |
| 44 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.10529569 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08154060 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04354227 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99690046 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99114862 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.96602575 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 0.89231242 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86326143 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86167750 |
| 53 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86036640 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 0.85857388 |
| 55 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.85124800 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.81743567 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77799092 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.72737837 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.72099245 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66120080 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64619691 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 0.64405306 |
| 63 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63861450 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62998559 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62446220 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.60534648 |
| 67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59749624 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58258504 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56408352 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54342762 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54102640 |
| 72 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51086089 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51032762 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49523111 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46715809 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.46146620 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44728297 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44482543 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43889094 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43202330 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42516115 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41322469 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40327163 |
| 84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39445104 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38864693 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38387866 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38357310 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37560265 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36318682 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36193695 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.35422158 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33981433 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.33486276 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33462099 |
| 95 | Morphine addiction_Homo sapiens_hsa05032 | 0.30220698 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28104555 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25579814 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24199839 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.23594679 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23181556 |

